In other medical conditions, GLP-1 receptor agonists have been shown to reduce inflammatory cytokines, lower oxidative stress, and improve visceral inflammation
Breaking that medicine into smaller doses would make it hard to measure a consistent dose and increases your risk of infection (from reusing the syringe)
The L-cells that produce GLP-1 possess nutrient-sensing receptors that respond to specific molecular signals from digested food
TB-500 has even less human research than BPC-157
Related research context BPC-157 is part of the peptide-based healing and tissue repair research class, commonly studied in models involving angiogenesis, extracellular matrix remodeling, and soft-tissue recovery
Divino V, DeKoven M, Khan FA, et al